US 12,480,089 · Application 17/916,421 · Granted Nov 25, 2025
US 12,480,089
Antiviral treatment comprising blis containing probiotic products
Estimated expiration
November 29, 2042
16y 44d remaining
- Could not fetch continuity data for application PCTNZ2021050054: Resource not found (404)
Earliest effective filing
Mar 31, 2021
+ 20 years
Mar 31, 2041
PTA +608d
Nov 29, 2042
No TD
—
Final
Nov 29, 2042
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- September 30, 2022
- Earliest effective filing
- March 31, 2021
- Issue date
- November 25, 2025
- PTA
- +608 days
- Base expiry (before PTA)
- March 31, 2041
March 31, 2021 + 20 years = March 31, 2041 + 608 PTA days = November 29, 2042
- National stage entry of application PCTNZ2021050054, filed Mar 31, 2021
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 17/916,421 · US 12,480,089
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 12,480,089: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US12480089Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.